PCQI Insights
PCQI Requirements vs FDA Dietary Supplement Disease Claims
Quick answer: dietary supplement disease claims are not a PCQI sign-off issue. First decide which manufacturing and food safety rules apply, then assign PCQI tasks. A PCQI’s food safety role does not replace regulatory review of disease claims, and it never means FDA has approved them.
A Preventive Controls Qualified Individual (PCQI) performs functions required by the preventive controls rule in 21 CFR Part 117. Dietary supplement manufacturing, however, follows a separate CGMP framework in 21 CFR Part 111. Marketing statements raise yet another question: whether the product is being sold as a drug.
So businesses should not treat PCQI training as approval of promotional claims. This article explains why the two questions are separate, and who should answer each one.
Why Part 117 May Not Apply to a Supplement Facility
Under 21 CFR 117.5(e), subparts C and G of Part 117 do not apply to the manufacturing, processing, packaging or holding of a dietary supplement that complies with Part 111 and section 761 of the FD&C Act (serious adverse event reporting).
Subpart C contains the hazard analysis, the food safety plan and the PCQI duties in 21 CFR 117.180. As a result, a supplement-only operation in compliance with Part 111 may have no PCQI duties at all. Part 111 sets its own personnel requirements instead.
However, some facilities also make conventional foods. Those activities may still fall under Part 117. Therefore, map each product and activity before you assign roles.
Who Decides Whether a Statement Is a Disease Claim?
Disease claims are a different legal question. Under 21 U.S.C. 321(g)(1)(B), articles intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease are drugs. For supplements, 21 CFR 101.93(g) defines what counts as a disease claim.
In addition, 21 CFR 101.93(f) states that a product marketed as a dietary supplement whose labeling bears a disease claim is subject to regulation as a drug, unless the claim is an authorized health claim for which the product qualifies.
A food safety hazard analysis asks whether the product or process could harm the consumer. Claim review asks what the product is intended to do. Consequently, claim decisions belong with qualified regulatory reviewers, not with the PCQI by default. Statements about treating disease, preventing cardiovascular conditions or relieving inflammatory disorders all need that escalation.
Six Compliance Areas to Review
1. Identify the correct food safety pathway
Assess whether Part 117, Part 111, an exemption or another framework applies to each facility and product.
2. Define PCQI responsibilities accurately
Assign preventive controls oversight only where the applicable rule requires it. Do not assume the PCQI role governs all dietary supplement manufacturing.
3. Separate hazard identification from intended-use classification
A hazard analysis looks at potential harm from the product and the process. Disease-related promotional claims, in contrast, can change how FDA classifies the product.
4. Document product and process changes
Make sure that formula, supply chain, processing and intended-use changes trigger the right technical and regulatory reviews.
5. Set up qualified claims-review escalation
Route statements about treating or preventing disease to people with the right regulatory expertise. Then record who reviewed each statement and what they decided.
6. Verify training and decision records
Keep evidence that staff understand their assigned food safety roles. Likewise, keep records showing that qualified reviewers documented each claim decision.
Dietary Supplement Disease Claims Checklist
✓ Confirm whether Part 111, Part 117 or another framework governs the product.
✓ Document assigned PCQI and CGMP responsibilities, as applicable.
✓ Maintain accurate food safety and manufacturing records.
✓ Escalate disease claims to qualified regulatory review.
✓ Track changes and corrective actions through controlled procedures.
Above all, review product claims before publication. That way, marketing decisions and documented compliance responsibilities stay aligned.
Frequently Asked Questions
Is a PCQI mandatory for every dietary supplement manufacturer?
No. The required personnel qualifications depend on which framework applies. A supplement operation in compliance with Part 111 is exempt from Part 117 subparts C and G under 117.5(e), and Part 111 imposes its own requirements.
Can a PCQI approve disease-treatment claims?
No. PCQI status alone gives no authority to approve such claims under FDA drug requirements. Claim decisions need qualified regulatory review.
Does a product become compliant because the facility has a food safety plan?
No. Manufacturing requirements and promotional intended-use requirements must be assessed separately.
PCQI Insights
Related Reading
PCQI Requirements vs Supplement Testimonial Claims
How testimonials, social media posts and ads can signal drug intended use.
Read article →
PCQI vs. Dietary Supplement Website Claims
Why blogs and web pages that link to sales pages need claim review, not a PCQI sign-off.
Read article →
Dietary Supplement PCQI: Which FDA Rules Apply?
Classify products and activities, and decide whether a PCQI is required at all.
Read article →
Need Help Managing Your PCQI Responsibilities?
Talk with our team about your products, current documentation, regulatory questions and possible next steps.
Independent educational content. PCQI Services is not affiliated with or endorsed by the U.S. Food and Drug Administration (FDA) or any company referenced in regulatory materials. This content is for general information only and does not constitute regulatory approval, certification or legal advice. Regulatory applicability must be assessed for each product, facility and operation. Read our terms.
